Therapeutics
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
| RFA-NS-22-070 | HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain(R01 Clinical Trial Not Allowed) | HHS-NIH11 | 08/09/2022 | 03/06/2024 |
| RFA-NS-22-059 | Early-Stage Therapy Development for ADRD (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 08/02/2022 | 10/31/2022 |
| RFA-NS-23-003 | HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices (RM1 Clinical Trial Optional) | HHS-NIH11 | 08/01/2022 | 06/09/2025 |
| RFA-NS-22-055 | Functional Target Validation for Alzheimer's Disease-Related Dementias (ADRDs) (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 07/21/2022 | 11/08/2022 |
| PAR-22-216 | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) | HHS-NIH11 | 07/14/2022 | 07/01/2025 |
| PAR-22-189 | Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) | HHS-NIH11 | 07/12/2022 | 09/11/2025 |
| PAR-22-170 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 07/07/2022 | 09/07/2025 |
| PAR-22-211 | Impact of the Microbiome-Gut-Brain Axis on Alzheimer's Disease and Alzheimer's Disease-Related Dementias (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 07/05/2022 | 10/05/2022 |
| RFA-AI-22-050 | Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/27/2022 | 12/07/2022 |
| RFA-AG-23-033 | Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 06/22/2022 | 10/21/2022 |
| PAR-22-185 | Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed) | HHS-NIH11 | 05/27/2022 | 01/17/2025 |
| RFA-AI-22-038 | A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) | HHS-NIH11 | 05/27/2022 | 10/13/2022 |
| RFA-OD-22-007 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 04/05/2022 | 07/01/2024 |
| PAR-22-139 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-086 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-085 | Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 02/18/2022 | 05/07/2025 |
| PAR-22-111 | Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 02/04/2022 | 01/07/2025 |
| PAR-22-100 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) | HHS-NIH11 | 02/03/2022 | 10/17/2024 |
| PAR-22-101 | Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 02/03/2022 | 10/17/2024 |
| PAR-22-082 | Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) | HHS-NIH11 | 02/03/2022 | 05/07/2025 |
| RFA-HL-23-010 | Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| RFA-HL-23-011 | Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| RFA-HL-23-012 | Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed) | HHS-NIH11 | 01/24/2022 | 12/20/2024 |
| PAR-22-058 | Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) | HHS-NIH11 | 01/21/2022 | 05/01/2023 |
| RFA-NS-22-034 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/07/2022 | 12/06/2024 |
| RFA-MH-22-135 | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) | HHS-NIH11 | 12/23/2021 | 10/15/2022 |
| RFA-MH-22-136 | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) | HHS-NIH11 | 12/23/2021 | 10/15/2022 |
| PAR-22-031 | Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) | HHS-NIH11 | 11/29/2021 | 01/07/2025 |
| PAR-22-071 | Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 11/23/2021 | 11/17/2024 |
| PAR-21-342 | Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) | HHS-NIH11 | 11/19/2021 | 12/13/2023 |
| PAR-22-032 | Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) | HHS-NIH11 | 11/17/2021 | 01/07/2025 |
| PAR-22-028 | Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) | HHS-NIH11 | 11/09/2021 | 09/30/2024 |
| PAR-21-355 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) | HHS-NIH11 | 11/09/2021 | 11/16/2024 |
| PAR-21-354 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional) | HHS-NIH11 | 11/09/2021 | 11/16/2024 |
| PAR-21-353 | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional) | HHS-NIH11 | 11/09/2021 | 11/05/2024 |
| PAR-21-329 | Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) | HHS-NIH11 | 09/22/2021 | 11/05/2024 |
| PAR-21-338 | Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed) | HHS-NIH11 | 09/22/2021 | 09/13/2024 |
| PAR-21-264 | Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) | HHS-NIH11 | 07/07/2021 | 11/01/2023 |
| PAR-21-246 | HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) | HHS-NIH11 | 07/06/2021 | 12/08/2022 |
| RFA-ES-21-006 | CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 06/25/2021 | 09/20/2023 |
| PAR-21-240 | Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) | HHS-NIH11 | 06/14/2021 | 03/11/2024 |
| PAR-21-241 | NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) | HHS-NIH11 | 06/14/2021 | 03/11/2024 |
| RFA-NS-21-029 | HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed) | HHS-NIH11 | 06/08/2021 | 10/10/2023 |
| PAR-21-211 | Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) | HHS-NIH11 | 04/01/2021 | 03/16/2024 |
| PAR-21-210 | Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) | HHS-NIH11 | 04/01/2021 | 03/05/2024 |
| RFA-NS-21-016 | HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) | HHS-NIH11 | 03/11/2021 | 10/10/2023 |
| PAR-21-123 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 03/11/2021 | 02/20/2024 |
| PAR-21-124 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 03/11/2021 | 02/20/2024 |
| PAR-21-122 | Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) | HHS-NIH11 | 03/11/2021 | 02/20/2024 |
| PAR-21-131 | Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-135 | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-129 | Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-130 | Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-137 | Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-136 | Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-134 | Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| PAR-21-132 | Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) | HHS-NIH11 | 03/02/2021 | 02/15/2024 |
| RFA-DA-22-010 | Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) | HHS-NIH11 | 02/26/2021 | 10/25/2022 |
| PAR-21-100 | Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) | HHS-NIH11 | 12/23/2020 | 02/05/2023 |
| PAR-21-073 | NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) | HHS-NIH11 | 12/01/2020 | 06/09/2023 |
| PAR-21-033 | National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) | HHS-NIH11 | 11/12/2020 | 01/07/2024 |
| RFA-AI-20-076 | New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 10/20/2020 | 03/17/2023 |
| PAR-20-300 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) | HHS-NIH11 | 09/11/2020 | 12/09/2022 |
| PAR-20-299 | Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) | HHS-NIH11 | 09/11/2020 | 12/09/2022 |
| PAR-20-293 | Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) | HHS-NIH11 | 09/10/2020 | 05/17/2023 |
| PAR-20-264 | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 08/10/2020 | 09/07/2023 |
| PAR-20-263 | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 08/10/2020 | 09/07/2023 |
| PAR-20-253 | Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 07/07/2020 | 05/30/2023 |
| PAR-20-180 | Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) | NIH | 04/30/2020 | 09/07/2023 |
| PAR-20-161 | Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) | NIH | 04/02/2020 | 03/17/2023 |
| PAR-20-157 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) | NIH | 03/31/2020 | 05/07/2023 |
| PAR-20-159 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) | NIH | 03/31/2020 | 05/07/2023 |
| PA-20-146 | NIDA Small Research Grant Program (R03 Clinical Trial Required) | NIH | 03/24/2020 | 05/07/2023 |
| PAR-20-072 | NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) | NIH | 12/09/2019 | 09/07/2022 |
| PAR-20-063 | NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) | NIH | 11/22/2019 | 01/07/2023 |
| PAR-19-328 | Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) | HHS | 08/05/2019 | 09/08/2022 |
| PAR-19-289 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | NIH | 05/29/2019 | 09/07/2022 |